Objectives: To investigate the efficiency of piracetam
and acyclovir in treating sudden hearing loss.
Patients and Methods: Eightyone patients (44 males, 37
females; mean age 40.4 year; range 18 to 72 years) who
had treatment between January 2002 and December
2006 with diagnosis of idiopathic sudden hearing loss were
evaluated retrospectively. These patients were divided into
four groups according to the treatment they received. The
patients who had combined treatment constituted the first
group; those who had combined treatment and piracetam
the second; those who had combined treatment and
acyclovir the third; those who had combined treatment,
acyclovir, and piracetam the fourth group.
Results: For the four treatment groups, in the pre-and
post-treatment (10th day) evaluation of the treatment
efficiency made by calculation of the hearing thresholds
in 250-8000 Hz frequencies, no significant difference
between the groups was determined (p>0.05).
Conclusion: No additional benefit was obtained
with acyclovir and piracetam in treatment.
FREE FULL TEXTAnahtar Kelimeler: Asiklovir; pirasetam; ani işitme kaybı.